1. Home
  2. STVN vs KNX Comparison

STVN vs KNX Comparison

Compare STVN & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • KNX
  • Stock Information
  • Founded
  • STVN 1949
  • KNX 1989
  • Country
  • STVN Italy
  • KNX United States
  • Employees
  • STVN N/A
  • KNX N/A
  • Industry
  • STVN Containers/Packaging
  • KNX Trucking Freight/Courier Services
  • Sector
  • STVN Consumer Discretionary
  • KNX Industrials
  • Exchange
  • STVN Nasdaq
  • KNX Nasdaq
  • Market Cap
  • STVN 7.4B
  • KNX 7.0B
  • IPO Year
  • STVN 2021
  • KNX 1994
  • Fundamental
  • Price
  • STVN $22.87
  • KNX $45.86
  • Analyst Decision
  • STVN Buy
  • KNX Strong Buy
  • Analyst Count
  • STVN 4
  • KNX 17
  • Target Price
  • STVN $25.88
  • KNX $53.65
  • AVG Volume (30 Days)
  • STVN 360.6K
  • KNX 2.8M
  • Earning Date
  • STVN 11-06-2025
  • KNX 10-22-2025
  • Dividend Yield
  • STVN 0.27%
  • KNX 1.57%
  • EPS Growth
  • STVN 19.61
  • KNX 280.63
  • EPS
  • STVN 0.60
  • KNX 0.88
  • Revenue
  • STVN $1,373,219,524.00
  • KNX $7,477,640,000.00
  • Revenue This Year
  • STVN $8.33
  • KNX $2.37
  • Revenue Next Year
  • STVN $10.12
  • KNX $5.58
  • P/E Ratio
  • STVN $38.31
  • KNX $52.19
  • Revenue Growth
  • STVN 6.97
  • KNX N/A
  • 52 Week Low
  • STVN $17.81
  • KNX $36.69
  • 52 Week High
  • STVN $28.00
  • KNX $61.51
  • Technical
  • Relative Strength Index (RSI)
  • STVN 45.20
  • KNX 57.90
  • Support Level
  • STVN $20.67
  • KNX $41.35
  • Resistance Level
  • STVN $24.01
  • KNX $44.72
  • Average True Range (ATR)
  • STVN 1.23
  • KNX 1.54
  • MACD
  • STVN 0.06
  • KNX 0.17
  • Stochastic Oscillator
  • STVN 45.08
  • KNX 85.73

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: